Sep 19 2012
COPENHAGEN A new Danish film made on a shoestring budget with a partly amateur cast confronts the global scourge of piracy on the high seas through a psychological drama about negotiations to free a vessel and crew seized by Somali marauders.
Sep 19 2012
COPENHAGEN A new Danish film made on a shoestring budget with a partly amateur cast confronts the global scourge of piracy on the high seas through a psychological drama about negotiations to free a vessel and crew seized by Somali marauders.
Sep 19 2012
COPENHAGEN A new Danish film made on a shoestring budget with a partly amateur cast confronts the global scourge of piracy on the high seas through a psychological drama about negotiations to free a vessel and crew seized by Somali marauders.
Aug 23 2012
COPENHAGEN Scientists gathering data to underpin a claim by Denmark to a vast Arctic Ocean tract including the North Pole have harvested crucial new information about the seabed and toasted their arrival at the pole with sparkling wine.
Aug 22 2012
COPENHAGEN Danish wind turbine maker Vestas unveiled plans on Wednesday for 1,400 more job cuts to save an extra 100 million euros ($125 million), as it battened down the hatches for another difficult year in 2013.
Aug 22 2012
COPENHAGEN Danish wind turbine maker Vestas revealed plans for 1,400 more job cuts on Wednesday as it battened down the hatches for another difficult year in 2013.
Aug 14 2012
COPENHAGEN Pension funds hunting for higher returns are buying direct equity stakes in wind power projects that are being shunned as too risky by banks and other investors.
Jul 27 2012
COPENHAGEN Denmark will dispatch a scientific expedition to the Arctic Ocean at the end of the month to gather data before it submits a formal claim to a vast tract north of Greenland that includes the North Pole.
Jul 19 2012
LONDON/COPENHAGEN Electronics maker Bang & Olufsen is taking on two little-known strategic investors as it looks to increase sales tenfold in China and catch up luxury rivals in the world's largest market.
Jul 18 2012
COPENHAGEN Novo Nordisk's bid to challenge Sanofi's dominance of the long-lasting insulin market hit another snag after U.S. regulators delayed approval of the Danish drugmaker's degludec until after an expert review.